title: Cognitive function as an emerging treatment target for marijuana addiction.
abstract: Cannabis is the most widely used illicit substance in the world, and demand for effective treatment is increasing. However, abstinence rates following behavioral therapies have been modest, and there are no effective pharmacotherapies for the treatment of cannabis addiction. We propose a novel research agenda and a potential treatment strategy, based on observations that both acute and chronic exposure to cannabis are associated with dose-related cognitive impairments, most consistently in attention, working memory, verbal learning, and memory functions. These impairments are not completely reversible upon cessation of marijuana use, and moreover may interfere with the treatment of marijuana addiction. Therefore, targeting cognitive impairment associated with chronic marijuana use may be a promising novel strategy for the treatment of marijuana addiction. Preclinical studies suggest that medications enhancing the cholinergic transmission may attenuate cannabis-induced cognitive impairments, but these cognitive enhancing medications have not been examined in controlled human studies. Preliminary evidence from individuals addicted to other drugs suggests that computerized cognitive rehabilitation may also have utility to improve cognitive function in marijuana users. Future clinical studies optimally designed to measure cognitive function as well as drug use behavior would be needed to test the efficacy of these treatments for marijuana addiction.
authors.affiliation: Department of Psychiatry, Yale University School of Medicine, and VA Connecticut Healthcare System, West Haven, Connecticut 06516, USA. mehmet.sofuoglu@yale.edu
authors.forename: Mehmet
authors.initials: M
authors.lastname: Sofuoglu
authors.forename: Dawn E
authors.initials: DE
authors.lastname: Sugarman
authors.forename: Kathleen M
authors.initials: KM
authors.lastname: Carroll
mesh_terms: D000818:Animals; D001521:Behavior Therapy / Q000379:methods; D002186:Cannabinoids / Q000494:pharmacology / Q000627:therapeutic use; D018679:Cholinergic Agonists / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000150:complications / Q000188:drug therapy* / Q000628:therapy; D016503:Drug Delivery Systems / Q000379:methods*; D006801:Humans; D002189:Marijuana Abuse / Q000150:complications / Q000534:rehabilitation / Q000628:therapy*; D018377:Neurotransmitter Agents / Q000627:therapeutic use*; D013813:Therapy, Computer-Assisted / Q000379:methods*
chemical_list: D002186:Cannabinoids; D018679:Cholinergic Agonists; D018377:Neurotransmitter Agents
references.citation: Exp Clin Psychopharmacol. 2010 Feb;18(1):87-98
references.pmid: 20158298
references.citation: Am J Addict. 2007 Sep-Oct;16(5):331-42
references.pmid: 17882603
references.citation: Addiction. 2002 Dec;97 Suppl 1:109-24
references.pmid: 12460133
references.citation: Can J Neurol Sci. 2007 Mar;34 Suppl 1:S109-17
references.pmid: 17469693
references.citation: Neuropsychopharmacology. 2003 Jul;28(7):1356-65
references.pmid: 12784123
references.citation: Life Sci. 2002 Dec 20;72(4-5):397-407
references.pmid: 12467880
references.citation: Br J Pharmacol. 1995 Jul;115(6):869-70
references.pmid: 7582512
references.citation: Neuroscience. 2000;95(1):5-7
references.pmid: 10619457
references.citation: Neuroscience. 2003;120(4):1149-56
references.pmid: 12927219
references.citation: Ann N Y Acad Sci. 2007 Dec;1121:576-97
references.pmid: 17846151
references.citation: Am J Cardiol. 1988 Feb 24;61(7):15D-17D
references.pmid: 2894151
references.citation: J Pharmacol Exp Ther. 2007 Jun;321(3):1127-34
references.pmid: 17351107
references.citation: Curr Drug Abuse Rev. 2008 Jan;1(1):81-98
references.pmid: 19630708
references.citation: Am J Addict. 2009 May-Jun;18(3):185-93
references.pmid: 19340636
references.citation: Neurosci Biobehav Rev. 2009 May;33(5):631-46
references.pmid: 18835296
references.citation: Expert Opin Ther Targets. 2009 May;13(5):551-67
references.pmid: 19368497
references.citation: Exp Clin Psychopharmacol. 2008 Dec;16(6):484-97
references.pmid: 19086769
references.citation: Neurotoxicol Teratol. 2005 Mar-Apr;27(2):231-9
references.pmid: 15734274
references.citation: Int Psychogeriatr. 2002;14 Suppl 1:93-126
references.pmid: 12636182
references.citation: Br J Pharmacol. 2000 Jul;130(6):1201-10
references.pmid: 10903956
references.citation: Eur J Pharmacol. 1998 Aug 21;355(2-3):119-24
references.pmid: 9760025
references.citation: Life Sci. 1995;56(23-24):2119-26
references.pmid: 7776840
references.citation: Psychopharmacology (Berl). 2001 Sep;157(2):142-50
references.pmid: 11594438
references.citation: Am J Psychiatry. 2008 Mar;165(3):335-41; quiz 409
references.pmid: 18245177
references.citation: PLoS One. 2007 Nov 07;2(11):e1143
references.pmid: 17989775
references.citation: Eur J Pharmacol. 2009 Aug 1;615(1-3):102-7
references.pmid: 19470387
references.citation: Drug Alcohol Depend. 2007 Jan 5;86(1):22-9
references.pmid: 16769180
references.citation: Addict Behav. 2007 Jun;32(6):1220-36
references.pmid: 16996224
references.citation: Am J Drug Alcohol Abuse. 2005;31(3):359-69
references.pmid: 16161723
references.citation: Behav Neurosci. 2001 Feb;115(1):243-6
references.pmid: 11256448
references.citation: J Consult Clin Psychol. 2000 Oct;68(5):898-908
references.pmid: 11068976
references.citation: Psychopharmacology (Berl). 2006 Apr;185(3):358-68
references.pmid: 16521034
references.citation: Neuropsychobiology. 2003;48(2):95-101
references.pmid: 14504418
references.citation: Proc Natl Acad Sci U S A. 1990 Mar;87(5):1932-6
references.pmid: 2308954
references.citation: Naunyn Schmiedebergs Arch Pharmacol. 1995 Nov;352(5):576-9
references.pmid: 8751088
references.citation: Neuropsychopharmacology. 2008 Sep;33(10):2505-16
references.pmid: 18185500
references.citation: Drug Alcohol Depend. 2002 May 1;66(3):265-73
references.pmid: 12062461
references.citation: Addict Biol. 2009 Jan;14(1):22-31
references.pmid: 18855805
references.citation: J Consult Clin Psychol. 2006 Apr;74(2):307-16
references.pmid: 16649875
references.citation: Handb Exp Pharmacol. 2005;(168):691-717
references.pmid: 16596793
references.citation: Neurosci Biobehav Rev. 2006;30(5):680-95
references.pmid: 16574226
references.citation: Addict Sci Clin Pract. 2007 Dec;4(1):4-16
references.pmid: 18292704
references.citation: Drug Alcohol Depend. 2006 Dec 1;85(3):205-12
references.pmid: 16725282
references.citation: J Addict Dis. 2001;20(1):49-72
references.pmid: 11286431
references.citation: Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):358-69
references.pmid: 15249273
references.citation: Drug Alcohol Depend. 2005 Nov 1;80(2):147-59
references.pmid: 15899556
references.citation: Arch Gen Psychiatry. 2001 Apr;58(4):322-8
references.pmid: 11296091
references.citation: J Consult Clin Psychol. 2000 Dec;68(6):1051-61
references.pmid: 11142539
references.citation: Addiction. 2008 Nov;103(11):1896-904
references.pmid: 19032539
references.citation: Eur Neurol. 2005;54(1):39-45
references.pmid: 16118495
references.citation: Arch Gen Psychiatry. 2008 Jun;65(6):694-701
references.pmid: 18519827
references.citation: J Consult Clin Psychol. 2006 Oct;74(5):955-66
references.pmid: 17032099
references.citation: Neuropsychopharmacology. 2001 Nov;25(5):757-65
references.pmid: 11682259
references.citation: Psychopharmacology (Berl). 2008 Mar;197(1):157-68
references.pmid: 18161012
references.citation: Mol Pharmacol. 2006 Oct;70(4):1236-45
references.pmid: 16855179
references.citation: Alzheimer Dis Assoc Disord. 2008 Jan-Mar;22(1):30-8
references.pmid: 18317244
references.citation: Annu Rev Physiol. 2009;71:283-306
references.pmid: 19575681
references.citation: Clin Psychol Rev. 2007 Jul;27(6):750-9
references.pmid: 17292521
references.citation: Addiction. 2005 May;100(5):612-8
references.pmid: 15847618
references.citation: Mini Rev Med Chem. 2009 Jun;9(7):769-81
references.pmid: 19519502
references.citation: J Psychopharmacol. 2009 May;23(3):266-77
references.pmid: 18719045
references.citation: Psychopharmacology (Berl). 1995 Jun;119(3):282-90
references.pmid: 7675962
references.citation: Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593
references.pmid: 16437532
references.citation: Neurology. 2002 Nov 12;59(9):1337-43
references.pmid: 12427880
references.citation: Braz J Psychiatry. 2008 Sep;30(3):271-80
references.pmid: 18833429
references.citation: Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005336
references.pmid: 16856093
references.citation: Neuropharmacology. 2001 Sep;41(3):392-9
references.pmid: 11522331
references.citation: Annu Rev Psychol. 2007;58:1-23
references.pmid: 17029565
references.citation: Prog Neurobiol. 2007 Oct;83(2):69-91
references.pmid: 17681661
references.citation: Pharmacol Biochem Behav. 1999 May;63(1):137-42
references.pmid: 10340534
references.citation: Arch Gen Psychiatry. 2001 Oct;58(10):909-15
references.pmid: 11576028
references.citation: CNS Drugs. 2009 Nov;23(11):939-52
references.pmid: 19845415
references.citation: Drug Alcohol Depend. 2008 Jun 1;95(3):279-83
references.pmid: 18329188
references.citation: Pharmacol Biochem Behav. 1977 Aug;7(2):99-103
references.pmid: 918141
references.citation: Neuropsychobiology. 1998;37(2):104-11
references.pmid: 9566276
references.citation: Neuropsychopharmacology. 2006 Oct;31(10):2296-303
references.pmid: 16572123
references.citation: Neuropharmacology. 2002 Jun;42(8):993-1007
references.pmid: 12128000
references.citation: Psychopharmacology (Berl). 1987;91(1):20-4
references.pmid: 3029792
references.citation: Neuroreport. 2000 Jun 26;11(9):2025-9
references.pmid: 10884065
references.citation: Addiction. 2008 Nov;103(11):1809-18
references.pmid: 18778385
references.citation: Neuropsychopharmacology. 2010 Feb;35(3):764-74
references.pmid: 19924114
references.citation: J Clin Psychol. 1992 Jul;48(4):539-43
references.pmid: 1325478
references.citation: JAMA. 2002 Mar 6;287(9):1123-31
references.pmid: 11879109
references.citation: Neuroreport. 2000 Mar 20;11(4):749-53
references.pmid: 10757513
references.citation: Pharmacol Biochem Behav. 1990 Nov;37(3):561-5
references.pmid: 1965045
references.citation: Expert Opin Emerg Drugs. 2009 Mar;14(1):43-65
references.pmid: 19249987
references.citation: J Forensic Sci. 2008 Jan;53(1):90-4
references.pmid: 18279244
references.citation: J Consult Clin Psychol. 2004 Jun;72(3):455-66
references.pmid: 15279529
references.citation: Biol Psychiatry. 1995 May 15;37(10):731-9
references.pmid: 7640328
references.citation: J Forensic Sci. 2000 Jan;45(1):24-30
references.pmid: 10641915
references.citation: Brain Res. 1998 Oct 26;809(1):1-4
references.pmid: 9795096
references.citation: Pflugers Arch. 2003 Apr;446(1):17-29
references.pmid: 12690458
references.citation: Drug Alcohol Depend. 2006 Feb 28;81(3):313-22
references.pmid: 16171953
references.citation: Psychopharmacology (Berl). 1989;99(3):397-401
references.pmid: 2594907
references.citation: Addict Biol. 2005 Jun;10(2):171-80
references.pmid: 16191670
references.citation: Neuropsychol Rev. 2007 Sep;17(3):317-36
references.pmid: 17690986
references.citation: J Consult Clin Psychol. 2006 Jun;74(3):628-32
references.pmid: 16822119
references.citation: Curr Alzheimer Res. 2009 Aug;6(4):362-7
references.pmid: 19689235
references.citation: Psychol Addict Behav. 2006 Sep;20(3):241-53
references.pmid: 16938062
references.citation: BMJ. 2005 Jan 1;330(7481):11
references.pmid: 15574485
references.citation: Brain Cogn. 2006 Mar;60(2):203-4
references.pmid: 16646121
references.citation: Neuropsychopharmacology. 2002 Apr;26(4):479-88
references.pmid: 11927172
references.citation: J Clin Psychiatry. 1979 Sep;40(9):397-8
references.pmid: 479116
references.citation: J Int Neuropsychol Soc. 2003 Jul;9(5):679-89
references.pmid: 12901774
references.citation: Pharmacol Rev. 2002 Jun;54(2):161-202
references.pmid: 12037135
references.citation: Clin Interv Aging. 2008;3(2):211-25
references.pmid: 18686744
references.citation: Br J Pharmacol. 2002 Jan;135(2):564-78
references.pmid: 11815392
references.citation: Br J Pharmacol. 2007 Nov;152(5):567-75
references.pmid: 17906678
references.citation: Addiction. 2010 Jan;105(1):38-48
references.pmid: 20078461
references.citation: Int Rev Neurobiol. 2005;64:1-122
references.pmid: 16096020
references.citation: Neuroimage. 2004 Nov;23(3):914-20
references.pmid: 15528091
references.citation: J Subst Abuse Treat. 2008 Jun;34(4):407-14
references.pmid: 17869051
references.citation: Drug Alcohol Depend. 2009 Oct 1;104(3):220-7
references.pmid: 19592176
references.citation: Handb Exp Pharmacol. 2005;(168):299-325
references.pmid: 16596779
references.citation: Annu Rev Neurosci. 2007;30:57-78
references.pmid: 17417935
references.citation: Exp Clin Psychopharmacol. 2008 Apr;16(2):113-23
references.pmid: 18489015
references.citation: J Neurosci. 2004 Dec 8;24(49):11017-22
references.pmid: 15590917
references.citation: Brain Res Cogn Brain Res. 2005 Apr;23(1):107-18
references.pmid: 15795138
references.citation: Eur J Neurosci. 2004 May;19(10):2682-92
references.pmid: 15147302
references.citation: Eur J Neurosci. 2003 Jul;18(1):109-16
references.pmid: 12859343
references.citation: Addiction. 2007 Sep;102(9):1443-53
references.pmid: 17645430
references.citation: Prog Brain Res. 2004;145:67-78
references.pmid: 14650907
references.citation: Eur J Pharmacol. 1997 May 26;327(1):R1-2
references.pmid: 9185841
references.citation: Hum Psychopharmacol. 2006 Mar;21(2):127-8
references.pmid: 16482609
references.citation: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 15;31(8):1593-600
references.pmid: 17900777
references.citation: Arch Gen Psychiatry. 2004 Nov;61(11):1136-44
references.pmid: 15520361
references.citation: Behav Pharmacol. 1999 Sep;10(5):497-511
references.pmid: 10780256
references.citation: Nature. 1971 Oct 1;233(5318):343-5
references.pmid: 5000625
references.citation: Drug Alcohol Depend. 1995 Apr;38(1):25-34
references.pmid: 7648994
references.citation: Psychopharmacology (Berl). 2009 Jul;205(1):171-4
references.pmid: 19300982
references.citation: J Int Neuropsychol Soc. 2007 Sep;13(5):807-20
references.pmid: 17697412
references.citation: J Neurosci. 1999 Aug 15;19(16):6795-805
references.pmid: 10436037
references.citation: Lancet. 2009 Oct 17;374(9698):1383-91
references.pmid: 19837255
references.citation: Drug Alcohol Depend. 2003 Apr 1;69(3):303-10
references.pmid: 12633916
references.citation: J Consult Clin Psychol. 1994 Feb;62(1):92-9
references.pmid: 8034835
references.citation: Biol Psychiatry. 2007 Jan 1;61(1):31-40
references.pmid: 16631130
references.citation: Eur J Pharmacol. 1999 Aug 20;379(1):R1-2
references.pmid: 10499380
references.citation: Arch Gen Psychiatry. 2001 Aug;58(8):763-8
references.pmid: 11483142
references.citation: Alcohol Clin Exp Res. 1984 Sep-Oct;8(5):470-5
references.pmid: 6391258
references.citation: JAMA. 1996 Feb 21;275(7):521-7
references.pmid: 8606472
references.citation: Pharmacol Res. 2004 Oct;50(4):433-40
references.pmid: 15304240
references.citation: J Pharmacol Exp Ther. 2008 Feb;324(2):664-73
references.pmid: 17967938
references.citation: JAMA. 2004 May 5;291(17):2114-21
references.pmid: 15126440
references.citation: Psychopharmacology (Berl). 1998 Nov;140(1):11-9
references.pmid: 9862397
references.citation: Learn Mem. 2007 Jan 03;14(1-2):63-74
references.pmid: 17202425
references.citation: Drug Alcohol Depend. 2005 Aug 1;79(2):211-23
references.pmid: 16002030
references.citation: Neuropsychopharmacology. 2008 Jul;33(8):1798-806
references.pmid: 17895916
references.citation: Drug Alcohol Depend. 2003 Aug 20;71(2):207-11
references.pmid: 12927659
references.citation: Am J Psychiatry. 2005 Aug;162(8):1403-13
references.pmid: 16055761
references.citation: Exp Clin Psychopharmacol. 2003 Feb;11(1):34-45
references.pmid: 12622342